Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS.
about
Toward precision medicine in amyotrophic lateral sclerosisTranslating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRINew developments and future opportunities in biomarkers for amyotrophic lateral sclerosisPresymptomatic studies in ALS: rationale, challenges, and approachLessons of ALS imaging: Pitfalls and future directions - A critical reviewWhat does imaging reveal about the pathology of amyotrophic lateral sclerosis?25 years of neuroimaging in amyotrophic lateral sclerosis.Neuroimaging to investigate multisystem involvement and provide biomarkers in amyotrophic lateral sclerosisAge related changes in metabolite concentrations in the normal spinal cord.Multiple kernel learning captures a systems-level functional connectivity biomarker signature in amyotrophic lateral sclerosis.Virtual brain biopsies in amyotrophic lateral sclerosis: Diagnostic classification based on in vivo pathological patternsMechanisms, models and biomarkers in amyotrophic lateral sclerosisControversies and priorities in amyotrophic lateral sclerosis.Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype.Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis.Spinal cord markers in ALS: diagnostic and biomarker considerations.Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis.Effect of respiration on the B0 field in the human spinal cord at 3T.ZNStress: a high-throughput drug screening protocol for identification of compounds modulating neuronal stress in the transgenic mutant sod1G93R zebrafish model of amyotrophic lateral sclerosisGrey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality.Opportunity and innovation in studying pre-symptomatic amyotrophic lateral sclerosis.Relationship between cervical cord 1H-magnetic resonance spectroscopy and clinoco-electromyographic profile in amyotrophic lateral sclerosis.Mind the gap: the mismatch between clinical and imaging metrics in ALS.Neuroimaging in amyotrophic lateral sclerosisThe selective anatomical vulnerability of ALS: ‘disease-defining’ and ‘disease-defying’ brain regions
P2860
Q26764950-5108FAF5-4490-4E98-AA09-F9459262D3A3Q26767048-61D4DB44-7026-4483-8148-585C7DE55B15Q26783410-7E8D503C-D28D-4AA1-9AB8-76B520D04FFDQ26824988-50FDE658-341A-433F-AB2D-1E3469F08EC7Q26860864-FB39DE25-7A36-4D4B-893D-9D5B6C7F8115Q27007017-DE236F06-2390-41A2-AB60-EC25B3D364B5Q30659482-2506EEA5-36A9-45FF-AFFC-55917DF80586Q30832443-2762C1D4-FEE5-4ABF-8DA2-5A7AE7EC5F6AQ30859766-DD57353F-0D5B-4E18-9281-F6B74DFE234AQ31147229-243EC482-001F-41E1-B82C-462A16391909Q33822826-0AD12006-9B6D-41B1-AA13-545CD00DE3CFQ34344992-2B3F7AF7-233C-41B1-AFC5-C825C26096A6Q36045826-45DC6BCF-7E82-4C6A-AC24-3AF8B78F2151Q37497445-AD0681E5-2B52-4E72-9316-D70289B09BDCQ37561488-45D44299-D9B5-4DCB-AF57-DBEB5087477EQ37983648-F6633B3C-833A-401F-BD90-50A7AD5486CBQ38384260-50168790-0A4C-4EF6-97CB-32A736EBC639Q39279646-4DB45EE7-D0F6-4419-B3AE-F7B9ADD2AEBEQ41865521-A703C75B-FF8E-4A83-BCBB-D8A0B0461B2CQ43739867-6D3A968C-48AD-4809-A508-879A8F29D732Q46114577-2D942362-362C-4504-A7D5-5C837B6FB5A8Q48346568-95F26BFA-0BB7-454F-B36A-AFEB89B5B643Q48377031-3BB30B1C-466F-4891-8C6F-2047D9DC143DQ57498892-C3CC4CDC-57A8-4977-A0CC-76AAD1842845Q58125306-CA0D6F18-8A48-45C5-A94D-7DBAB713F589
P2860
Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Presymptomatic spinal cord neu ...... ople at risk for familial ALS.
@ast
Presymptomatic spinal cord neu ...... ople at risk for familial ALS.
@en
type
label
Presymptomatic spinal cord neu ...... ople at risk for familial ALS.
@ast
Presymptomatic spinal cord neu ...... ople at risk for familial ALS.
@en
prefLabel
Presymptomatic spinal cord neu ...... ople at risk for familial ALS.
@ast
Presymptomatic spinal cord neu ...... ople at risk for familial ALS.
@en
P2093
P2860
P1433
P1476
Presymptomatic spinal cord neu ...... ople at risk for familial ALS.
@en
P2093
P M Andersen
P2860
P304
P356
10.1212/WNL.0B013E318231526A
P407
P577
2011-09-21T00:00:00Z